Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...
Hosted on MSN
Lasting HIV treatment possible with RNA strategy
* Scientists used a natural RNA to suppress HIV's reactivation * It acts like a brake mechanism to stop viral activity * Could lead to a permanent treatment strategy in the //future A promising study ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment responses of adults with HIV who are ...
A randomized clinical trial led by Johns Hopkins researchers finds that giving patients a next-day HIV viral load (VL) test ...
Experts and activists have warned that complacency may cause a resurgence of the epidemic that has claimed more than 40 million people. A number of young people do not think HIV is not a problem ...
Mark was diagnosed in 1985 with HIV in Chicago. It was the same week Rock Hudson died from AIDS; Mark had been extremely sick ...
The Daily Monitor on MSN
Why has HIV/AIDS remained huge burden in Lango
The sub-region has 96,200 people living with HIV, with 2,090 new infections reported in 2024, including 350 new infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback